203 related articles for article (PubMed ID: 37777579)
21. Tumour treating fields therapy for glioblastoma: current advances and future directions.
Rominiyi O; Vanderlinden A; Clenton SJ; Bridgewater C; Al-Tamimi Y; Collis SJ
Br J Cancer; 2021 Feb; 124(4):697-709. PubMed ID: 33144698
[TBL] [Abstract][Full Text] [Related]
22. DDRI-9: a novel DNA damage response inhibitor that blocks mitotic progression.
Jun DW; Hwang M; Kim YH; Kim KT; Kim S; Lee CH
Oncotarget; 2016 Apr; 7(14):17699-710. PubMed ID: 26848527
[TBL] [Abstract][Full Text] [Related]
23. Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields.
Chang E; Pohling C; Beygui N; Patel CB; Rosenberg J; Ha DH; Gambhir SS
J Neurooncol; 2017 Sep; 134(2):259-268. PubMed ID: 28681243
[TBL] [Abstract][Full Text] [Related]
24. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
[TBL] [Abstract][Full Text] [Related]
25. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
Shi W; Blumenthal DT; Oberheim Bush NA; Kebir S; Lukas RV; Muragaki Y; Zhu JJ; Glas M
J Neurooncol; 2020 Jul; 148(3):489-500. PubMed ID: 32535723
[TBL] [Abstract][Full Text] [Related]
26. Tumor treating fields with radiation for glioblastoma: a narrative review.
Miller R; Niazi M; Russial O; Poiset S; Shi W
Chin Clin Oncol; 2022 Oct; 11(5):40. PubMed ID: 36336899
[TBL] [Abstract][Full Text] [Related]
27. Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields.
Giladi M; Schneiderman RS; Porat Y; Munster M; Itzhaki A; Mordechovich D; Cahal S; Kirson ED; Weinberg U; Palti Y
Pancreatology; 2014; 14(1):54-63. PubMed ID: 24555979
[TBL] [Abstract][Full Text] [Related]
28. First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis.
Kassubek R; Mathieu R
Brain Sci; 2022 Apr; 12(4):. PubMed ID: 35448029
[TBL] [Abstract][Full Text] [Related]
29. Acceptance and compliance of TTFields treatment among high grade glioma patients.
Onken J; Staub-Bartelt F; Vajkoczy P; Misch M
J Neurooncol; 2018 Aug; 139(1):177-184. PubMed ID: 29644485
[TBL] [Abstract][Full Text] [Related]
30. Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients.
Gagg H; Williams ST; Conroy S; Myers KN; McGarrity-Cottrell C; Jones C; Helleday T; Rantala J; Rominiyi O; Danson SJ; Collis SJ; Wells G
F1000Res; 2023; 12():954. PubMed ID: 37799492
[TBL] [Abstract][Full Text] [Related]
31. An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma.
Swanson KD; Lok E; Wong ET
Curr Neurol Neurosci Rep; 2016 Jan; 16(1):8. PubMed ID: 26739692
[TBL] [Abstract][Full Text] [Related]
32. Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.
Jones AB; Schanel TL; Rigsby MR; Griguer CE; McFarland BC; Anderson JC; Willey CD; Hjelmeland AB
Cells; 2023 Aug; 12(17):. PubMed ID: 37681903
[TBL] [Abstract][Full Text] [Related]
33. Real-Time Monitoring of the Effect of Tumour-Treating Fields on Cell Division Using Live-Cell Imaging.
Le HT; Staelens M; Lazzari D; Chan G; Tuszyński JA
Cells; 2022 Aug; 11(17):. PubMed ID: 36078119
[TBL] [Abstract][Full Text] [Related]
34. Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating Fields.
Linder B; Schiesl A; Voss M; Rödel F; Hehlgans S; Güllülü Ö; Seifert V; Kögel D; Senft C; Dubinski D
Front Oncol; 2021; 11():715031. PubMed ID: 34395289
[TBL] [Abstract][Full Text] [Related]
35. Tumor treating fields: a new standard treatment for glioblastoma?
Taillibert S; Le Rhun E; Chamberlain MC
Curr Opin Neurol; 2015 Dec; 28(6):659-64. PubMed ID: 26551239
[TBL] [Abstract][Full Text] [Related]
36. Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]).
Shams S; Patel CB
J Mol Cell Biol; 2022 Dec; 14(8):. PubMed ID: 35973687
[TBL] [Abstract][Full Text] [Related]
37. Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical Development.
Gill SJ; Wijnhoven PWG; Fok JHL; Lloyd RL; Cairns J; Armenia J; Nikkilä J; Lau A; Bakkenist CJ; Galbraith SM; Vens C; O'Connor MJ
Mol Cancer Ther; 2021 Sep; 20(9):1614-1626. PubMed ID: 34158341
[TBL] [Abstract][Full Text] [Related]
38. Combined DNA Damage Repair Interference and Ion Beam Therapy: Development, Benchmark, and Clinical Implications of a Mechanistic Biological Model.
Liew H; Meister S; Mein S; Tessonnier T; Kopp B; Held T; Haberer T; Abdollahi A; Debus J; Dokic I; Mairani A
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):802-817. PubMed ID: 34710524
[TBL] [Abstract][Full Text] [Related]
39. Tumor treating fields as novel combination partner in the multimodal treatment of head and neck cancer.
Regnery S; Franke H; Held T; Trinh T; Naveh A; Abraham Y; Hörner-Rieber J; Hess J; Huber PE; Debus J; Lopez Perez R; Adeberg S
Head Neck; 2023 Apr; 45(4):838-848. PubMed ID: 36872620
[TBL] [Abstract][Full Text] [Related]
40. Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis.
Du X; Chen C; Xiao Y; Cui Y; Yang L; Li X; Liu X; Wang R; Tan B
Front Oncol; 2022; 12():1055366. PubMed ID: 36439464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
